VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma

Surgical Oncology

Volumn 20, Issue 1, 2011, Pages 13-19

  Zhou, Quan ^a   Zhu, Yong ^b   Deng, Zhansheng ^b   Long, Haitao ^b   Zhang, Shaoxian ^a   Chen, Xingli ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Clinical Pathology; EMMPRIN; Osteosarcoma; Survival; VEGF

Indexed keywords

CD147 ANTIGEN; VASCULOTROPIN;

ADULT; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW;

ADOLESCENT; ADULT; ANTIGENS, CD147; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OSTEOSARCOMA; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 78650847136     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2009.09.002     Document Type: Review

References (31)

1. A. Longhi, C. Errani, and M. De Paolis Primary bone osteosarcoma in the pediatric age: state of the art Cancer Treat Rev 32 2006 423 436
2. A.J. Chou, and R. Gorlick Chemotherapy resistance in osteosarcoma: current challenges and future directions Expert Rev Anticancer Ther 6 2006 1075 1085
3. I. Brian, W. Rini, and R. Kimryn Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma Clin Cancer Res 13 2007 741s 746s
4. A. Kolmakova, M. Rajesh, D. Zang, R. Pili, and S. Chatterjee VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo Glycoconj J 26 2009 547 558
5. N. Ferrara Vascular endothelial growth factor as a target for anticancer therapy The Oncologist 9 2004 2 10
6. C.G. Willett, Y. Boucher, and E. Tomaso Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Nat Med 10 2004 145 147
7. H.C. Zheng, H. Takahashi, Y. Murai, Z.G. Cui, K. Nomoto, and S. Miwa Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis Br J Cancer 95 2006 1371 1378
8. S.M. Ranuncolo, E. Armanasco, and C. Cresta Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of survival in breast cancer patients Int J Cancer 106 2003 745 751
9. T. Kanekura, X. Chen, and T. Kanzaki Basigin (EMMPRIN) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts Int J Cancer 99 2002 520 528
10. K. Nabeshima, H. Iwasaki, and K. Koga Emmprin (basigin/EMMPRIN): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression Pathol Int 56 2006 359 367
11. T. Asai, T. Ueda, K. Itoh, K. Yoshioka, Y. Aoki, and S. Mori Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung Int J Cancer 76 1998 418 422
12. M. Kaya, T. Wada, T. Akatsuka, S. Kawaguchi, S. Nagoya, and M. Shindoh Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis Clin Cancer Res 6 2000 572 577
13. D. Wang, L. Chen, and F. Gao Correlation of tumor microvessel density with prognosis in osteogenic sarcoma Chinese J Pathol 26 1997 266 269
14. M. Kreuter, R. Bieker, S.S. Bielack, T. Auras, H. Buerger, and G. Gosheger Prognostic relevance of increased angiogenesis in osteosarcoma Clin Cancer Res 10 2004 8531 8537
15. Y.H. Lee, T. Tokunaga, Y. Oshika, R. Suto, K. Yanagisawa, and M. Tomisawa Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma Eur J Cancer 35 1999 1089 1093
16. M. Kaya, T. Wada, and S. Kawaguchi Increased pretherapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma Br J Cancer 86 2002 864 869
17. W.F. Enneking, S.S. Spanier, and M.A. Goodman A system for the surgical staging of musculoskeletal sarcoma Clin Orthop Relat Res 153 1980 106 120
18. M. Salzer-Kuntschik, G. Delling, G. Beron, and R. Sigmund Morphological grades of regression in osteosarcoma after polychemotherapy-study COSS 80 J Cancer Res Clin Oncol 106 Suppl 1983 21 24
19. Y. Oshika, M. Nakamura, and T. Tokunaga Expression of cellassociated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer Int J Oncol 12 1998 541 544
20. D. Yin, T. Jia, W. Gong, H. Yu, P.H. Wooley, and M.P. Mott VEGF blockade decelerates the growth of a murine experimental osteosarcoma Int J Oncol 33 2008 253 259
21. I. Yoshio, M. Tomoe, and N. Mikio EMMPRIN and Matrix Metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma Cancer 101 2004 1994 2000
22. L. Jia, H. Zhou, and S. Wang Deglycosylation of CD147 down-regulates matrix metalloproteinase-11 expression and the adhesive capability of murine hepatocarcinoma cell HcaF in vitro IUBMB Life 58 2006 209 216
23. E. Maquoi, B.G. Galvez, and C. Gilles Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases J Biol Chem 279 2004 13564 13574
24. Y. Tang, M.T. Nakada, P. Kesavan, F. McCabe, H. Millar, and P. Rafferty Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases Cancer Res 65 2005 3193 3199
25. M.C. Madigan, E.A. Kingsley, P.J. Cozzi, W.J. Delprado, P.J. Russell, and Y. Li The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression Cancer Immunol Immunother 57 2008 1367 1379
26. N. Vigneswaran, S. Beckers, S. Waigel, J. Mensah, J. Wu, and J. Mo Increased EMMPRIN (CD 147) expression during oral carcinogenesis Exp Mol Pathol 80 2006 147 159
27. S. Zucker, M. Hymowitz, E.E. Rollo, R. Mann, C.E. Conner, and J. Cao Tumorigenic potential of extracellular matrix metalloproteinase inducer Am J Pathol 158 2001 1921 1928
28. E.E. Gabison, S. Mourah, E. Steinfels, L. Yan, T. Hoang-Xuan, and M.A. Watsky Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction Am J Pathol 166 2005 209 219
29. M.F. van der Jagt, F.C. Sweep, and E.T. Waas Correlation of reversion-inducing cysteinerich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer Cancer Lett 237 2006 289 297
30. H. Voigt, C.S. Vetter-Kauczok, D. Schrama, U.B. Hofmann, J.C. Becker, and R. Houben CD147 impacts angiogenesis and metastasis formation Cancer Invest 27 2009 329 333
31. Y.X. Liang, H.C. He, Z.D. Han, X.C. Bi, Q.S. Dai, and Y.K. Ye CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value Cancer Invest 27 2009 788 793